FIBRO | FIBROMAT (M) BERHAD
0.655 (-2.96%)
T-O (am): 0.000 (08:59:00)
Last updated: 12:10
FIBRO Fundamental Trend
FCON Ratio: Not enough data.
FIBRO Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Nov 25 | Q3 Sep 25 | 3 | 31 Dec 25 | 28.02 | 6.09 | 4.63 | 16.5% | 0.00 | 2.05 | 4.5% | 3.3% | ||||||||||
| 28 Aug 25 | Q2 Jun 25 | 2 | 31 Dec 25 | 29.34 | 6.27 | 4.49 | 15.3% | 0.00 | 1.99 | 119.7% | 251.8% | ||||||||||
| 28 Apr 25 | Q1 Mar 25 | 1 | 31 Dec 25 | 13.35 | 1.86 | 1.27 | 9.6% | 0.00 | 0.59 |
FIBRO Historical Dividends
FIBRO Financial Ratios
| EPS | 5.19 sen |
| Trailing PE (Sector Median: 13.2) | 12.6 |
| PEG | 3.82 |
| Altman Z | 2.0 |
| Beaver | -0.098 |
| Current Ratio | 2.53 |
| Debt-Equity (DE) Ratio | 0.52 |
| FCF Yield | -12.4 % |
| Revenue QoQ | -4.47 % |
| Revenue YoY | 0% |
| Profit QoQ | 3.3 % |
| Profit YoY | 0 % |
| Profit Margin (Sector Median: 4.1) | 17.06 % |
| ROE (ROIC: 14.05) | 15.71 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
FIBRO Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 13.2) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 4.1) | |
| ROE (ROIC: 17.09) | |
| Altman Z |
FIBRO Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 2 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.33 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 6.41 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
FIBRO Directors Share Purchases (Beta)
No transaction in the last 2 months.
FIBRO Summary
Market Cap: 162 M.
Market Cap Class: Micro caps
Number of Shares: 248 M.
Adjusted Float: 0%.
Fibromat (M) Berhad, incorporated in 2012 and headquartered in Batu Caves, Selangor, Malaysia, is a prominent provider of geotechnical solutions focused on erosion control, ground improvement, and sediment control. The company specializes in designing, manufacturing, and installing geotechnical solutions using geosynthetics, erosion control products, and biomass materials. Fibromat also engages in trading a wide range of geosynthetics, offering innovative solutions for diverse applications, including residential and commercial developments, infrastructure projects, and environmental protection initiatives. Through its integrated approach and advanced capabilities, Fibromat supports clients in achieving sustainable and cost-effective outcomes across Malaysia's evolving infrastructure landscape.
Sectors: Industrial Products & Services, Industrial Services
Code: 0355
Website: http://www.fibromatberhad.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
FIBRO Top Shareholdings
Updated on 02-Dec-2025
| Shareholder | % | Value (M) |
|---|---|---|
| Ng Kian Boon | 63.9% | 103.91 |
| Encik Mohd Tarmim Bin Sidek | 0.85% | 1.38 |
| Ng Chun Hou | 0.48% | 0.79 |
| Dr Fauziah Binti Ahmad | 0.06% | 0.1 |
| Loo Pak Soon | 0.02% | 0.03 |
| Ilham Binti Umar Thabii | 0.01% | 0.01 |
| Chao Kar Po | 0.01% | 0.01 |
Frequently Asked Questions
FIBROMAT (M) BERHAD Latest News
FIBRO Insights+
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham ProResearch House Target Price
Average Target Price: N/A
Entitlements
(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
Private Placements
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |